MSB 2.67% 96.0¢ mesoblast limited

Ann: MSB Q3 Financial Results and Operational Highlights, page-127

  1. 7,920 Posts.
    lightbulb Created with Sketch. 627
    I agree with your sentiment but yesterdays accidental slip that we have wasted a fair bit of time with a failed assay and SI telling us …no problem next quarter …then next quarter….then next quarter ….well we have run out of quarters up our sleeve and the FDA is not helping
    All I am saying is it will be a close run thing Basically we have until the end of September and I am getting anxious I am not selling but just verbalising how I am feeling
    It all boils down to getting our application over the line before the end of August so the deals can be made
    No FDA approval no deals
    No deal means trouble
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
96.0¢
Change
0.025(2.67%)
Mkt cap ! $1.096B
Open High Low Value Volume
95.0¢ 96.5¢ 94.0¢ $1.231M 1.291M

Buyers (Bids)

No. Vol. Price($)
4 94461 95.0¢
 

Sellers (Offers)

Price($) Vol. No.
96.0¢ 61151 6
View Market Depth
Last trade - 16.10pm 12/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.